Full Press Release Details
Change of Director s Interest Notice
Change of Director s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to
ASX become ASX s property and may be made public.
Introduced 30/9/2001.
Name of Entity: PRIMA BIOMED LIMITED (ASX:PRR)
We (the entity) give ASX the
following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director: Mr Matthew Lehman
Notice: 09 October 2013
Part 1 - Change of director s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of
notifiable interest of a director should be disclosed in this part.
Direct or indirect interest
Nature of indirect interest N/A
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant interest.
Date of change 09 October 2013
held prior to change 1) Ordinary Fully Paid Shares
Direct 1,617,763 2,104,441
Total 1,617,763 2,104,441
2) American Depositary Receipts (ADR)
+ See chapter 19 for defined
11/3/2002 Appendix 3Y Page 1
Change of Director s Interest Notice
2) American Depositary Receipts (ADR) traded on
1 ADR = 30 ordinary fully paid shares
Number acquired 1) Ordinary Fully Paid Shares
2) American Depositary Receipts (ADR)
Value/Consideration US$ 4,040.00
Note: If consideration is non-cash, provide details andestimated valuation
No. of securities held after change 1) Ordinary Fully Paid Shares
Direct 1,617,763 2,104,441
Total 1,617,763 2,104,441
2) American Depositary Receipts (ADR)
+ See chapter 19 for defined terms.
Appendix 3Y Page 2 11/3/2002
Change of Director s Interest Notice
Example: on-market trade, off-market trade, exercise of Acquiring 4,000 ADR s at US$1.01 each
that are options, issue of securities under dividend reinvestment traded on the NASDAQ plan, participation in buy-back
Part 2 Change of director s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of notifiable interest of a director should be disclosed in this part.
Detail of contract N/A
Name of registered holder
(if issued securities)
No. and class of securities to
which interest related prior to change
Note: Details are only required for a contract in relation to which the
interest has changed
Note: If consideration is
non-cash, provide details and an estimated valuation
Interest after change
Part 3 - +Closed Period
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? No
If so, was prior written clearance provided to allow the trade to proceed during this period?
If prior written clearance was provided on what date was this provided?
+ See chapter 19 for defined terms.